[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 12 - Case Supplement ::
Caspian J Intern Med 2021, 12 - Case Supplement : 491-494 Back to browse issues page
Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study
Maral Seyed Ahadi , Mohammad Ali Sahraian , Vahid Shaygannejad , Nassim Anjidani , Seyed Ehsan Mohammadiani Nejad , Nahid Beladi Moghadam , Hormoz Ayromlou , Gholam Ali Yousefi Pour , Sepideh Yazdanbakhsh , Mehrdad Jafari , Abdorreza Naser Moghadasi *
Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran , abdorrezamoghadasi@gmail.com
Abstract:   (1637 Views)
Background: Neuromyelitis optica spectrum disorder (NMOSD) is a neuroinflammatory disorder with a tendency to affect the spinal cord and optic nerves. As NMOSDs have a predilection for women of reproductive age and adopt an aggressive course during pregnancy, appropriate treatment strategies before conception and during pregnancy should be well-considered.
Case Presentation: In this report, the pregnancy outcome of eight pregnancies following rituximab treatment was assessed, which led to 50% live births with mean birth weight of 2777.50 (SD: 545.92) grams. Two patients had abortions due to doctor’s recommendation.  One pregnancy led to intrauterine fetal death (IUFD) due to nuchal cord.  No spontaneous abortions were encountered. Two patients received rituximab during pregnancy. No major malformations or serious neonatal infections were encountered.
Conclusion: Rituximab should be administered by caution in NMOSD patients who want to be pregnant and the probable adverse effects of the drug should be discussed by patients.
Keywords: Neuromyelitis Optica Spectrum Disorder, Rituximab, pregnancy
Full-Text [PDF 133 kb]   (628 Downloads)    
Type of Study: Case Series | Subject: Neurology
Received: 2020/12/31 | Accepted: 2021/04/6 | Published: 2021/07/24
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Seyed Ahadi M, Sahraian M A, Shaygannejad V, Anjidani N, Mohammadiani Nejad S E, Beladi Moghadam N, et al . Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study. Caspian J Intern Med 2021; 12 (S2) :491-494
URL: http://caspjim.com/article-1-2678-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 12 - Case Supplement Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4549